157 related articles for article (PubMed ID: 19404778)
41. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma.
Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y
Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
43. The prognostic role and reduced expression of FOXJ2 in human hepatocellular carcinoma.
Zhang Z; Meng G; Wang L; Ma Y; Guan Z
Mol Med Rep; 2016 Jul; 14(1):254-62. PubMed ID: 27177166
[TBL] [Abstract][Full Text] [Related]
44. The antioncogenic effect of Beclin-1 and FOXP3 is associated with SKP2 expression in gastric adenocarcinoma.
Kim HK; Won KY; Han SA
Medicine (Baltimore); 2021 Aug; 100(33):e26951. PubMed ID: 34414959
[TBL] [Abstract][Full Text] [Related]
45. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
46. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
47. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.
Chen M; Hu W; Xiong CL; Qu Z; Yin CQ; Wang YH; Luo CL; Guan Q; Yuan CH; Wang FB
Oncotarget; 2016 Dec; 7(49):80751-80764. PubMed ID: 27811373
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
[TBL] [Abstract][Full Text] [Related]
49. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
50. Soluble Egg Antigens of Schistosoma japonicum Induce Senescence of Activated Hepatic Stellate Cells by Activation of the FoxO3a/SKP2/P27 Pathway.
Duan Y; Pan J; Chen J; Zhu D; Wang J; Sun X; Chen L; Wu L
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005268. PubMed ID: 28036393
[TBL] [Abstract][Full Text] [Related]
51. Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma.
Kawakami K; Enokida H; Tachiwada T; Nishiyama K; Seki N; Nakagawa M
J Urol; 2007 Jul; 178(1):301-7. PubMed ID: 17499794
[TBL] [Abstract][Full Text] [Related]
52. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
53. Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Yang F; Lv L; Zhang K; Cai Q; Liu J; Jiang Y
Cell Physiol Biochem; 2017; 44(1):99-109. PubMed ID: 29131008
[TBL] [Abstract][Full Text] [Related]
54. Inter-regulation of IGFBP1 and FOXO3a unveils novel mechanism in ursolic acid-inhibited growth of hepatocellular carcinoma cells.
Yang LJ; Tang Q; Wu J; Chen Y; Zheng F; Dai Z; Hann SS
J Exp Clin Cancer Res; 2016 Mar; 35():59. PubMed ID: 27036874
[TBL] [Abstract][Full Text] [Related]
55. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
[TBL] [Abstract][Full Text] [Related]
56. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.
Shimoda Y; Ubukata Y; Handa T; Yokobori T; Watanabe T; Gantumur D; Hagiwara K; Yamanaka T; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Harimoto N; Katayama A; Hikino T; Sano T; Ogata K; Kuwano H; Shirabe K; Oyama T
BMC Cancer; 2018 May; 18(1):597. PubMed ID: 29801468
[TBL] [Abstract][Full Text] [Related]
57. Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2.
Hu JJ; Zhou C; Luo X; Luo SZ; Li ZH; Xu ZX; Xu MY
J Exp Clin Cancer Res; 2021 Jan; 40(1):26. PubMed ID: 33422101
[TBL] [Abstract][Full Text] [Related]
58. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
59. [Expressions of Thr187 phosphorylated p27(kip1) and Skp2 proteins in human hepatocellular carcinomas and their significances].
Wang Y; Chen L; Lu MD; Li P; Cui XP; Qin J; Shen AG
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):943-4. PubMed ID: 18171537
[No Abstract] [Full Text] [Related]
60. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.
Huang H; Regan KM; Wang F; Wang D; Smith DI; van Deursen JM; Tindall DJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1649-54. PubMed ID: 15668399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
